Invivyd, Inc. IVVD
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-08-06
Invivyd, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,473,808 | $4.9M | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 3,511,581 | $4.6M | 1.25% |
| TWO SIGMA INVESTMENTS, LP | 1,969,659 | $2.6M | 0.7% |
| CITADEL ADVISORS LLC | 1,680,375 | $2.2M | 0.6% |
| RENAISSANCE TECHNOLOGIES LLC | 846,265 | $1.1M | 0.3% |
| Point72 Asset Management, L.P. | 43,931 | $57,110 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.